Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy.
Eur J Clin Microbiol Infect Dis
; 31(8): 1833-6, 2012 Aug.
Article
em En
| MEDLINE
| ID: mdl-22187350
ABSTRACT
Antimicrobial-impregnated catheters are more expensive than standard catheters (S-C). A higher incidence of catheter-related bloodstream infection (CRBSI) has been found in jugular venous access with tracheostomy than without tracheostomy. The objective of this study was to determine central venous catheter (CVC)-related costs (considering only the cost of the CVC, diagnosis of CRBSI, and antimicrobial agents used to treat CRBSI) using rifampicin-miconazole-impregnated catheters (RM-C) or S-C in jugular venous access with tracheostomy. We performed a retrospective cohort study of patients admitted to the intensive care unit (ICU) with tracheostomy who received one or more jugular venous catheters. RM-C showed a lower incidence of CRBSI compared with S-C (0 vs. 20.16 CRBSI episodes/1,000 catheter-days; odds ratio=0.05; 95% confidence interval=0.001-0.32; p<0.001) and lower CVC-related costs (including the cost of the CVC, diagnosis, and treatment of CRBSI) (
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Rifampina
/
Cateterismo Venoso Central
/
Traqueostomia
/
Controle de Infecções
/
Cateteres Venosos Centrais
/
Miconazol
/
Anti-Infecciosos
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article